# Clustering Approach 7 : MRNASEQ_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.00309589370131835	Range of duration = 0.1 to 173.79, nDeath = 85, nCensor = 119
2	AGE	ANOVA	0.00813480383531374	Range of values = 39 to 85, Mean = 67.467, StdDev = 8.43957, nMissing = 8
3	GENDER	Chi-square test	0.225238886300244	nTypes = 2 (FEMALE/MALE), nPatients = 59/161
4	KARNOFSKY.PERFORMANCE.SCORE	ANOVA	0.542550825768943	Range of values = 0 to 100, Mean = 17.7273, StdDev = 33.6095, nMissing = 176
5	HISTOLOGICAL.TYPE	Chi-square test	0.897044041159953	nTypes = 4 (LUNG BASALOID SQUAMOUS CELL CARCINOMA/LUNG PAPILLARY SQUAMOUS CELL CARCINOMA/LUNG PAPILLARY SQUAMOUS CELL CARICNOMA/LUNG SQUAMOUS CELL CARCINOMA- NOT OTHERWISE SPECIFIED (NOS)), nPatients = 6/1/1/212
6	PATHOLOGY.T	Chi-square test	0.0215071637124474	nTypes = 4 (T1/T2/T3/T4), nPatients = 51/133/23/13
7	PATHOLOGY.N	Chi-square test	0.673316711424464	nTypes = 4 (N0/N1/N2/N3), nPatients = 142/54/19/5
8	PATHOLOGICSPREAD(M)	Chi-square test	0.0795203427884663	nTypes = 3 (M0/M1/MX), nPatients = 203/4/9, nMissing = 4
9	TUMOR.STAGE	Chi-square test	0.667914514853417	nTypes = 4 (I/II/III/IV), nPatients = 114/54/46/4, nMissing = 2
10	RADIATIONS.RADIATION.REGIMENINDICATION	Chi-square test	0.398731692664508	nTypes = 2 (NO/YES), nPatients = 6/214
11	NEOADJUVANT.THERAPY	Chi-square test	0.245806639649286	nTypes = 2 (NO/YES), nPatients = 21/199
